ibr 70 mg Pill: yellow, capsule/oblong, 18mm
Generic Name: ibrutinib
The pill with imprint ibr 70 mg (Yellow, Capsule/Oblong, 18mm) has been identified as Imbruvica 70 mg and is used for Waldenström Macroglobulinemia, Graft Versus Host Disease, and Chronic Lymphocytic Leukemia. It belongs to the drug class BTK inhibitors and is not a controlled substance.
Images for ibr 70 mg
Imbruvica
- Generic Name
- ibrutinib
- Imprint
- ibr 70 mg
- Strength
- 70 mg
- Color
- Yellow
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- BTK inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pharmacyclics, Inc.
- National Drug Code (NDC)
- 57962-0070
See also:
More about Imbruvica (ibrutinib)
- Check interactions
- Compare alternatives
- Reviews (69)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: BTK inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.